Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rujescu

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|June 29, 2001
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patientsN Dahmen, M J Müller, S Germeyer, et al.
The American Journal of Psychiatry|May 1, 2001
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor geneM Schäfer, D Rujescu, I Giegling, et al.
Tissue Antigens|June 26, 2003
TNFA promoter polymorphisms and narcolepsyS Wieczorek, M Gencik, D Rujescu, et al.
Neuropsychologia|August 31, 2001
Assessment of handedness using a digitizing tablet: a new methodV Henkel, R Mergl, G Juckel, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 28, 2025
Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeksHans H Stassen, S Bachmann, R Bridler, et al.
The Pharmacogenomics Journal|November 3, 2004
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depressionA Szegedi, D Rujescu, A Tadic, et al.
Molecular Psychiatry|September 17, 2008
Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13C Francks, F Tozzi, A Farmer, et al.
Neuroscience Letters|January 11, 2015
Enhanced calcium responses to serotonin receptor stimulation in T-lymphocytes from schizophrenic patients--a pilot studyJ Genius, A Schellenberg, L Tchana-Duope, et al.
Pharmacopsychiatry|October 1, 2011
Predicting response to psychopharmacological treatment: survey of recent resultsH Stassen, I-G Anghelescu, J Angst, et al.
Molecular Psychiatry|October 2, 2021
Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 yearsH Stocker, L Perna, K Weigl, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|June 29, 2001
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patientsN Dahmen, M J Müller, S Germeyer, et al.
The American Journal of Psychiatry|May 1, 2001
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor geneM Schäfer, D Rujescu, I Giegling, et al.
Tissue Antigens|June 26, 2003
TNFA promoter polymorphisms and narcolepsyS Wieczorek, M Gencik, D Rujescu, et al.
Neuropsychologia|August 31, 2001
Assessment of handedness using a digitizing tablet: a new methodV Henkel, R Mergl, G Juckel, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 28, 2025
Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeksHans H Stassen, S Bachmann, R Bridler, et al.
The Pharmacogenomics Journal|November 3, 2004
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depressionA Szegedi, D Rujescu, A Tadic, et al.
Molecular Psychiatry|September 17, 2008
Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13C Francks, F Tozzi, A Farmer, et al.
Neuroscience Letters|January 11, 2015
Enhanced calcium responses to serotonin receptor stimulation in T-lymphocytes from schizophrenic patients--a pilot studyJ Genius, A Schellenberg, L Tchana-Duope, et al.
Pharmacopsychiatry|October 1, 2011
Predicting response to psychopharmacological treatment: survey of recent resultsH Stassen, I-G Anghelescu, J Angst, et al.
Molecular Psychiatry|October 2, 2021
Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 yearsH Stocker, L Perna, K Weigl, et al.
Pageof 11